Evidence map›Paper›PMID 40903492›Full record

ArticleLeukemia2025

Computational measurable residual disease assessment in acute myeloid leukemia: a retrospective validation in the HOVON-SAKK-132 trial.

Tim R Mocking, Lukas H Haaksma, Tom Reuvekamp, Angèle Kelder, Willemijn J Scholten, Lok Lam Ngai, Dimitri A Breems, Thomas Fischer, Bjørn T Gjertsen, Laimonas Griškevičius and 15 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Tim R MockingAmsterdam UMC, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0001-9170-4131
Lukas H HaaksmaAmsterdam UMC, Amsterdam, The Netherlands.ORCID http://orcid.org/0009-0008-2179-4870
Tom ReuvekampAmsterdam UMC, Amsterdam, The Netherlands.ORCID http://orcid.org/0009-0001-1346-6606
Angèle KelderAmsterdam UMC, Amsterdam, The Netherlands.
Willemijn J ScholtenAmsterdam UMC, Amsterdam, The Netherlands.
Lok Lam NgaiAmsterdam UMC, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0003-0969-3766
Dimitri A BreemsZiekenhuis aan de Stroom, Antwerpen, Belgium.
Thomas FischerOtto von Guericke University Hospital Magdeburg, Magdeburg, Germany.
Bjørn T GjertsenHaukeland University Hospital, Bergen, Norway.ORCID http://orcid.org/0000-0001-9358-9704
Laimonas GriškevičiusVilnius University Hospital Santaros Klinikos and Vilnius University, Vilnius, Lithuania.
Gunnar JuliussonSkanes University Hospital, Lund, Sweden.ORCID http://orcid.org/0000-0002-7911-7265
Johan A MaertensUniversity Hospital Gasthuisberg, Leuven, Belgium.ORCID http://orcid.org/0000-0003-4257-5980
Markus G ManzUniversity Hospital, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-4676-7931
Thomas PabstSwiss Group for Clinical Cancer Research, Bern, Switzerland.ORCID http://orcid.org/0000-0002-6055-5257
Jakob R PasswegSwiss Group for Clinical Cancer Research, Bern, Switzerland.
Kimmo PorkkaHelsinki University Hospital Cancer Center, Helsinki, Finland.
Peter J M ValkErasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0002-8857-9461
Patrycja GradowskaErasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.
Bob LöwenbergErasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0001-8982-5217
David C de LeeuwAmsterdam UMC, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0003-4591-8467
Jeroen J W M JanssenAmsterdam UMC, Amsterdam, The Netherlands.
Gert J OssenkoppeleAmsterdam UMC, Amsterdam, The Netherlands.
Arjan A van de LoosdrechtAmsterdam UMC, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0001-8311-983X
Jacqueline CloosAmsterdam UMC, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0001-9150-8026
Costa BachasAmsterdam UMC, Amsterdam, The Netherlands. c.bachas@amsterdamumc.nl.ORCID http://orcid.org/0000-0001-5983-6193

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40903492
PMCPMC12463663

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.